Dieter Volc
Parkinson's and Movement Disorder Institute(US)Boehringer Ingelheim (Austria)(AT)
Publications by Year
Research Areas
Parkinson's Disease Mechanisms and Treatments, Glioma Diagnosis and Treatment, Neurological disorders and treatments, Transcranial Magnetic Stimulation Studies, Botulinum Toxin and Related Neurological Disorders
Most-Cited Works
- → Safety and immunogenicity of the α-synuclein active immunotherapeutic PD01A in patients with Parkinson's disease: a randomised, single-blinded, phase 1 trial(2020)133 cited
- → Ropinirole is effective in the long‐term management of restless legs syndrome: A randomized controlled trial(2006)98 cited
- → Nutzen einer Add-On-Therapie mit dem synthetischen Cannabinomimetikum Nabilone bei Patienten mit chronischen Schmerzzuständen – eine randomisierte kontrollierte Studie(2006)94 cited
- → Nicotinamide adenine dinucleotide (NADH) — a new therapeutic approach to Parkinson's disease(1993)93 cited
- → A Phase 1 Randomized Trial of Specific Active α‐Synuclein Immunotherapies PD01A and PD03A in Multiple System Atrophy(2020)81 cited
- → Optimizing odor identification testing as quick and accurate diagnostic tool for Parkinson's disease(2016)68 cited